Could Albuminuria Be an Overlooked Marker of Thrombotic Risk? – RPTH Journal
RPTH Journal shared a post on LinkedIn about a recent article by Xiu Hong Yang et al, adding:
”Could albuminuria be an overlooked marker of thrombotic risk?
We usually think of the urine albumin-to-creatinine ratio (UACR) as a kidney or cardiovascular marker.
But what if it also reflects systemic thrombotic vulnerability?
A new prospective RPTH study of 419,282 UK Biobank participants examined the relationship between albuminuria and future arterial thromboembolism (ATE) and pulmonary embolism (PE).
Here’s the key signal:
- Moderate albuminuria (UACR 3–30 mg/mmol) increased ATE risk
- Severe albuminuria (>30 mg/mmol) increased the risk of both ATE and c
- Risk intensified further with reduced kidney function or low serum albumin
What’s changing under the hood:
- Albuminuria reflects endothelial dysfunction and vascular injury
- Associated with platelet activation and hypercoagulability
- Linked to inflammatory pathways (CRP, VWF, ADAMTS13)
- Suggests a systemic prothrombotic state – not just kidney disease
(Figures 1–3 show dose-dependent increases in thrombotic risk with rising UACR)
Translation:
Albuminuria may not simply mark renal injury; it may identify patients with heightened endothelial and thrombotic dysfunction.
Big questions for the field:
- Should UACR be incorporated into thrombosis risk assessment?
- Is albuminuria a mediator of thrombosis – or a marker of systemic vascular injury?
- Could aggressive treatment of albuminuria reduce thromboembolic events?”
Title: Urine albumin-to-creatinine ratio and risks of incident arterial thromboembolism and pulmonary embolism among adults—a prospective cohort study
Authors: Xiu Hong Yang, Yao Liu, Zhen Xing Zhang, Yi Jun Lu, Chen Sheng Fu, Hui Min Jin, Zhi Bin Ye, Xiao Li Zhang

Stay updated on all scientific advances with Hemostasis Today.
-
Jun 24, 2026, 09:29Advancing Women’s Health Through Collaboration with Jean Hailes for Women’s Health – Stroke Foundation
-
Jun 24, 2026, 09:18The Lasting Immunological Footprint of VITT – JTH
-
Jun 24, 2026, 09:09Umberto Pensato: Dedicated Funding Pathways for Stroke Research in Italy
-
Jun 24, 2026, 09:00Danny Gaskin: BBTS 2026 and the Evolving Role of Transfusion in Maternity Care
-
Jun 24, 2026, 07:46Wolfgang Miesbach: WFH’s First AAV Gene Therapy Chapter Marks a New Era in Hemophilia Care
-
Jun 24, 2026, 06:42Deepthi Krishna: World Blood Donor Day 2026 Celebrations at Rela Hospital
-
Jun 24, 2026, 03:36Ana Pedrero Gil: A New Approach to Post-Tonsillectomy Hemorrhage
-
Jun 24, 2026, 02:59Melissa Hollo: Making Early Anemia Detection the Standard of Care
-
Jun 24, 2026, 02:51Bruno Pougault: The Thin Line Between Bleeding and Clotting